Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.4M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
38.2M
-
Shares change
-
+19.2M
-
Total reported value, excl. options
-
$17.2M
-
Value change
-
+$6.98M
-
Number of buys
-
29
-
Number of sells
-
-37
-
Price
-
$0.45
Significant Holders of P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) as of Q2 2024
80 filings reported holding PIII - P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share as of Q2 2024.
P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.2M shares
.
Largest 10 shareholders include Alyeska Investment Group, L.P. (15.9M shares), ARMISTICE CAPITAL, LLC (7.9M shares), AMERIPRISE FINANCIAL INC (6.33M shares), VANGUARD GROUP INC (1.82M shares), EMFO, LLC (1.43M shares), MILLENNIUM MANAGEMENT LLC (594K shares), GEODE CAPITAL MANAGEMENT, LLC (478K shares), GOLDMAN SACHS GROUP INC (477K shares), BlackRock Inc. (411K shares), and JANE STREET GROUP, LLC (308K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.